Category(ies): Biotech Companies; Pharmaceutical Companies; R&D Institutions
Address: Biocant Park, Núcleo 4, Lote 3; 3060-197 Cantanhede; Portugal
Keyword(s): Advanced Therapies, Immunity, Infection, Pharmaceuticals, Research & Development
Immunethep is a biotech company developing Antibacterial Immunotherapies. Our focus is on understanding and enhancing how our immune system controls the infection. The immunotherapies being developed at Immunethep are the result of a discovery that different pathogenic bacteria share a common mechanism to evade from the host immune system using an immunosuppressive protein. With our immunotherapies, we are able to prevent or treat infections from the most critical human pathogenic bacteria including antibiotic-resistant strains such as Methicillin-Resistant Staphylococcus aureus (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE) blocking the immunosuppressive protein that is disabling the immune system response.
+351 231 419 042